跳至主要内容
临床试验/NCT06028971
NCT06028971进行中(未招募)不适用

Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case Series

41medical AG10 个研究点 分布在 2 个国家目标入组 60 人开始时间: 2024年2月29日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
41medical AG
入组人数
60
试验地点
10
主要终点
Occurrence of AEs/SAEs in the affected lower extremity/extremities

研究概览

简要总结

The goal of this observational multicenter case series is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care.

详细描述

The goal of this observational study is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care. The study is conducted as a retrospective and prospective multicenter case series. Eligible patients are those with fractures of the distal femur who are treated with the Biphasic Plate DF according to the Instruction for Use (IFU). The patient will be followed-up until healing or up to 12 months, whichever comes first.

To assess the safety and performance following data is collected:

  • incidents of AEs/SAEs occurring in the affected lower extremity/extremities
  • Bone healing assessed by a surgeon
  • Weightbearing and function
  • Patients' quality of life and pain level

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with fractures of the distal femur requiring internal fixation and treated with the Biphasic Plate DF as indicated according to the IFU. As per the IFU, the Biphasic Plate DF is indicated for:
  • Distal shaft fractures
  • Supracondylar fractures
  • Intraarticular fractures
  • Periprosthetic fractures
  • No other major implant beside the Biphasic Plate DF is used for fixation of the distal femur fracture, with the exceptions of lag screw(s) and/or cerclage wire(s), and/or a joint replacement.
  • Patients who are willing and able to comply with postoperative FUs per local standard of care.
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures.
  • Patients over 18 years of age

排除标准

  • (preoperatively):
  • Patient is participating in another interventional clinical trial.
  • Exclusion Criteria (intraoperatively):
  • Change of surgical plan intraoperatively at the discretion of the surgeon that Biphasic Plate DF is not used
  • Necessity to apply a second (medial) plate (double plating) or an intramedullary nail in case of critical fixation distally

结局指标

主要结局

Occurrence of AEs/SAEs in the affected lower extremity/extremities

时间窗: until clinically healed or up to 12 months

The primary outcome measure is the occurrence of AEs/SAEs in the affected lower extremity/extremities that are deemed related, probably related, or possibly related to the surgical procedure or the Biphasic Plate DF

次要结局

  • Bone Healing(until clinically healed or up to 12 months)
  • Patient-reported outcome measures(until clinically healed or up to 12 months)

研究者

发起方
41medical AG
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验